Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106183 · ClinicalTrials.gov registry record · NA
Efficacy of Transfer Factor to Prevent Upper Respiratory Tract Infections in Healthy Adults
A NA study of Upper Respiratory Tract Infections Due to Influenza or Rhinovirus, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT01106183: Completed NA study of Upper Respiratory Tract Infections Due to Influenza or Rhinovirus, sponsored by University of Utah.
NCT01106183 is a NA study of Upper Respiratory Tract Infections Due to Influenza or Rhinovirus that has completed, run by University of Utah. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01106183, a NA study of Upper Respiratory Tract Infections Due to Influenza or Rhinovirus, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of our study are to critically evaluate if a healthy population supplemented with Transfer factor experiences fewer incidences of colds and flu, or experience shorter duration of illness compared to an identical population taking placebo. In this study we will give either Transfer factor or a placebo to two groups of healthy adult men and women for a period of 7 weeks in a double-blind experimental design. The frequency and duration of colds and flu-like symptoms will be recorded during the course of the study. Saliva samples will be collected weekly and assessed for salivary IgA secretion rate. Data from this study will establish the efficacy of Transfer Factor to support a healthy immune system.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT transfer factor
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT01106183 record still lists
NCT01106183 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Upper Respiratory Tract Infections Due to Influenza or Rhinovirus appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01106183 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT01106183 about?
NCT01106183 is a clinical study titled "Efficacy of Transfer Factor to Prevent Upper Respiratory Tract Infections in Healthy Adults". The goals of our study are to critically evaluate if a healthy population supplemented with Transfer factor experiences fewer incidences of colds and flu, or experience shorter duration of illness compared to an identical population taking placebo. In this study we will give either Transfer factor o...
What is the current status of trial NCT01106183?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2010-01. Estimated completion is 2010-03.
What conditions does trial NCT01106183 study?
This clinical trial studies the following conditions: Upper Respiratory Tract Infections Due to Influenza or Rhinovirus.
What interventions are being tested in trial NCT01106183?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), transfer factor (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01106183?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01106183 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01106183's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia